Skip to main content Accessibility help

Critical steps in the isolation and expansion of adipose-derived stem cells for translational therapy

  • S. Riis (a1), V. Zachar (a1), S. Boucher (a2), M.C. Vemuri (a2), C. P. Pennisi (a1) and T. Fink (a1)...


Since the discovery of adipose-derived stem cells (ASCs), there have been high expectations of their putative clinical use. Recent advances support these expectations, and it is expected that the transition from pre-clinical and clinical studies to implementation as a standard treatment modality is imminent. However ASCs must be isolated and expanded according to good manufacturing practice guidelines and a basic assurance of quality, safety, and medical effectiveness is needed for authorisation by regulatory agencies, such as European Medicines Agency and US Food and Drug Administration. In this review, a collection of studies investigating the influence of different steps of the isolation and expansion protocol on the yield and functionality of ASCs has been presented in an attempt to come up with best recommendations that ensure potential beneficial clinical outcome of using ASCs in any therapeutic setting. If the findings confirm the initial observations of beneficial effects of ASCs, the path is paved for implementing these ASC-based therapies as standard treatment options.


Corresponding author

* Corresponding author: Trine Fink, Frederik Bajers vej 3B, 9220 Aalborg Ø, Denmark. E-mail:


Hide All
1. Rasmussen, J.G. et al. (2011) Prolonged hypoxic culture and trypsinization increase the pro-angiogenic potential of human adipose tissue-derived stem cells. Cytotherapy 13, 318-328
2. Lund, P. et al. (2009) Effect of growth media and serum replacements on the proliferation and differentiation of adipose-derived stem cells. Cytotherapy 11, 189-197
3. Melief, S.M. et al. (2013) Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Translational Medicine 2, 455-463
4. Baek, S.J., Kang, S.K. and Ra, J.C. (2011) In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Experimental and Molecular Medicine 43, 596
5. Smith, C.L. et al. (2015) Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer. Stem Cells Translational Medicine 4, 239-251
6. Lim, M.H., Ong, W.K. and Sugii, S. (2014) The current landscape of adipose-derived stem cells in clinical applications. Expert Reviews in Molecular Medicine 16, e8
7. Rodriguez, J.P. et al. (2012) Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety. International Archives of Medicine 5, 5
8. Pikuła, M. et al. (2013) Adipose tissue-derived stem cells in clinical applications. Expert Opinion on Biological Therapy 13, 1357-1370
9. Garcia-Olmo, D. et al. (2009) Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. International Journal of Colorectal Disease 24, 27-30
10. Qayyum, A.A. et al. (2012) Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regenerative Medicine 7, 421-428
11. Lee, H.C. et al. (2012) Safety and effect of adipose tissue-derived Stem cell implantation in patients with critical limb ischemia. Circulation Journal 76, 1750-1760
12. Bura, A. et al. (2014) Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy 16, 245-257
13. García-Olmo, D. et al. (2005) A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Diseases of the Colon and Rectum 48, 1416-1423
14. Cho, Y.B. et al. (2013) Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study. Cell Transplantation 22, 279-285
15. Lee, W.Y. et al. (2013) Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula. Stem Cells 31, 2575-2581
16. Garcia-Olmo, D. et al. (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Diseases of the Colon and Rectum 52, 79-86
17. De la Portilla, F. et al. (2013) Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial. International Journal of Colorectal Disease 28, 313-323
18. Herreros, M.D. et al. (2012) Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Diseases of the Colon and Rectum 55, 762-772
19. Ra, J.C. et al. (2011) Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells and Development 20, 1297-1308
20. Jo, C.H. et al. (2014) Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells 32, 1254-1266
21. Zheng, G. et al. (2014) Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respiratory Research 15, 39
22. Sándor, G.K. et al. (2014) Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-tissue defects. Stem Cells Translational Medicine 3, 530-540
23. Mesimäki, K. et al. (2009) Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. International Journal of Oral and Maxillofacial Surgery 38, 201-209
24. Kølle, S.-F.T. et al. (2013) Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet 382, 1113-1120
25. Wilson, A., Butler, P.E. and Seifalian, A.M. (2011) Adipose-derived stem cells for clinical applications: a review. Cell Proliferation 44, 86-98
26. Ra, J.C. et al. (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. Journal of Translational Medicine 9, 181
27. Voswinkel, J. et al. (2013) Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. Immunologic Research 56, 241-248
28. De Miguel, M.P. et al. (2012) Immunosuppressive properties of mesenchymal stem cells: advances and applications. Current molecular Medicine 12, 574-591
29. Mojallal, A. et al. (2011) Influence of age and body mass index on the yield and proliferation capacity of adipose-derived stem cells. Aesthetic Plastic Surgery 35, 1097-1105
30. Schipper, B.M. et al. (2008) Regional anatomic and age effects on cell function of human adipose-derived stem cells. Annals of Plastic Surgery 60, 538-544
31. De Barros, S. et al. (2013) Aging-related decrease of human ASC angiogenic potential is reversed by hypoxia preconditioning through ROS production. Molecular Therapy: the Journal of the American Society of Gene Therapy 21, 399-408
32. Van Harmelen, V., Röhrig, K. and Hauner, H. (2004) Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53, 632-637
33. Gu, J.H. et al. (2012) Neovascular potential of adipose-derived stromal cells (ASCs) from diabetic patients. Wound Repair and Regeneration 20, 243-252
34. Aguena, M. et al. (2012) Optimization of parameters for a more efficient use of adipose-derived stem cells in regenerative medicine therapies. Stem Cells International, Article ID303610, 7
35. Jurgens, W.J.F.M. et al. (2008) Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research 332, 415-426
36. Padoin, A.V. et al. (2008) Sources of processed lipoaspirate cells: influence of donor site on cell concentration. Plastic and Reconstructive Surgery 122, 614-618
37. Fraser, J.K. et al. (2007) Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots. Cytotherapy 9, 459-467
38. Aksu, A.E. et al. (2008) Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells. Annals of Plastic Surgery 60, 306-322
39. Buschmann, J. et al. (2013) Yield and proliferation rate of adipose-derived stromal cells as a function of age, body mass index and harvest site-increasing the yield by use of adherent and supernatant fractions? Cytotherapy 15, 1098-1105
40. Muscari, C. et al. (2013) Comparison between stem cells harvested from wet and dry lipoaspirates. Connective Tissue Research 54, 34-40
41. Sung, S.H. et al. (2012) The effects of lidocaine and procaine on microRNA expression of adipocyte-derived adult stem cells. Korean Journal of Anesthesiology 62, 552-557
42. Oedayrajsingh-Varma, M.J. et al. (2006) Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8, 166-177
43. Erdim, M. et al. (2009) The effects of the size of liposuction cannula on adipocyte survival and the optimum temperature for fat graft storage: an experimental study. Journal of Plastic, Reconstructive and Aesthetic Surgery 62, 1210-1214
44. Ozsoy, Z., Kul, Z. and Bilir, A. (2006) The role of cannula diameter in improved adipocyte viability: a quantitative analysis. Aesthetic Surgery Journal/the American Society for Aesthetic Plastic Surgery 26, 287-289
45. Alharbi, Z. et al. (2013) Conventional vs. micro-fat harvesting: how fat harvesting technique affects tissue-engineering approaches using adipose tissue-derived stem/stromal cells. Journal of Plastic, Reconstructive and Aesthetic Surgery 66, 1271-1278
46. Trivisonno, A. et al. (2014) Harvest of superficial layers of fat with a microcannula and isolation of adipose tissue-derived stromal and vascular cells. Aesthetic Surgery Journal/the American Society for Aesthetic Plastic Surgery 34, 601-613
47. Schreml, S. et al. (2009) Harvesting human adipose tissue-derived adult stem cells: resection versus liposuction. Cytotherapy 11, 947-957
48. Matsumoto, D. et al. (2007) Influences of preservation at various temperatures on liposuction aspirates. Plastic and Reconstructive Surgery 120, 1510-1517
49. Carvalho, P.P. et al. (2011) The effect of storage time on adipose-derived stem cell recovery from human lipoaspirates. Cells, Tissues, Organs 194, 494-500
50. Eom, Y.W. et al. (2011) Rapid isolation of adipose tissue-derived stem cells by the storage of lipoaspirates. Yonsei Medical Journal 52, 999-1007
51. Wang, W.Z. et al. (2015) The impact of short-term refrigeration of human lipoaspirate on adipose-derived stem cells and adipocytes. Journal of Plastic, Reconstructive and Aesthetic Surgery 68, 137-139
52. Zuk, P.A. et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering 7, 211-228
53. Riordan, N.H. et al. (2009) Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Journal of Translational Medicine 7, 29
54. Priya, N. et al. (2014) Explant culture: a simple, reproducible, efficient and economic technique for isolation of mesenchymal stromal cells from human adipose tissue and lipoaspirate. Journal of Tissue Engineering and Regenerative Medicine 8, 706-716
55. Shah, F.S. et al. (2013) A non-enzymatic method for isolating human adipose tissue-derived stromal stem cells. Cytotherapy 15, 979-985
56. Pilgaard, L. et al. (2008) Comparative analysis of highly defined proteases for the isolation of adipose tissue-derived stem cells. Regenerative Medicine 3, 705-715
57. Carvalho, P.P. et al. (2013) Xenofree enzymatic products for the isolation of human adipose-derived stromal/stem cells. Tissue Engineering, Methods 19, 473-478
58. Condé-Green, A., de Amorim, N.F.G. and Pitanguy, I. (2010) Influence of decantation, washing and centrifugation on adipocyte and mesenchymal stem cell content of aspirated adipose tissue: a comparative study. Journal of Plastic, Reconstructive and Aesthetic Surgery 63, 1375-1381
59. Condé-Green, A. et al. (2010) Effects of centrifugation on cell composition and viability of aspirated adipose tissue processed for transplantation. Aesthetic Surgery Journal/the American Society for Aesthetic Plastic Surgery 30, 249-255
60. Kurita, M. et al. (2008) Influences of centrifugation on cells and tissues in liposuction aspirates: optimized centrifugation for lipotransfer and cell isolation. Plastic and Reconstructive Surgery 121, 1033-1041; discussion 1042-3
61. Baer, P.C. et al. (2010) Human adipose-derived mesenchymal stem cells in vitro: evaluation of an optimal expansion medium preserving stemness. Cytotherapy 12, 96-106
62. Horn, P., Bork, S. and Wagner, W. (2011) Standardized isolation of human mesenchymal stromal cells with red blood cell lysis. Methods in Molecular Biology 698, 23-35
63. Zuk, P.A. et al. (2002) Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell 13, 4279-4295
64. Escobedo-Lucea, C. et al. (2013) A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses. PLoS ONE 8, e67870
65. Koller, M.R. et al. (1998) Tissue culture surface characteristics influence the expansion of human bone marrow cells. Biomaterials 19, 1963-1972
66. Foldberg, S. et al. (2012) Patterned poly(lactic acid) films support growth and spontaneous multilineage gene expression of adipose-derived stem cells. Colloids and Surfaces B, Biointerfaces 93, 92-99
67. Ho, M. et al. (2006) Comparison of standard surface chemistries for culturing mesenchymal stem cells prior to neural differentiation. Biomaterials 27, 4333-4339
68. Doi, K. et al. (2013) Stromal vascular fraction isolated from lipo-aspirates using an automated processing system: bench and bed analysis. Journal of Tissue Engineering and Regenerative Medicine 7, 864-870
69. Dos-Anjos Vilaboa, S., Navarro-Palou, M. and Llull, R. (2014) Age influence on stromal vascular fraction cell yield obtained from human lipoaspirates. Cytotherapy 16, 1092-1097
70. Güven, S. et al. (2012) Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax® technology. Tissue Engineering C, Methods 18, 575-582
71. Fraser, J.K. et al. (2014) The celution(®) system: automated processing of adipose-derived regenerative cells in a functionally closed system. Advances in Wound Care 3, 38-45
72. Lin, K. et al. (2008) Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 10, 417-426
73. Hicok, K.C. and Hedrick, M.H. (2011) Automated isolation and processing of adipose-derived stem and regenerative cells. Methods in Molecular Biology 702, 87-105
74. Aronowitz, J.a. and Ellenhorn, J.D.I. (2013) Adipose stromal vascular fraction isolation: a head-to-head comparison of four commercial cell separation systems. Plastic and Reconstructive Surgery 132, 932e-939e
75. Giancola, R., Bonfini, T. and Iacone, A. (2012) Cell therapy: cGMP facilities and manufacturing. Muscles, Ligaments and Tendons Journal 2, 243-247
76. Hourd, P. et al. (2014) StemBook, Harvard Stem Cell Institute, Harvard, MA.
77. Pikuła, M. et al. (2013) Adipose tissue-derived stem cells in clinical applications. Expert Opinion on Biological Therapy 13, 16-18
78. Lindroos, B. et al. (2009) Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro . Cytotherapy 11, 958-972
79. Wan Safwani, W.K.Z. et al. (2011) The changes of stemness biomarkers expression in human adipose-derived stem cells during long-term manipulation. Biotechnology and Applied Biochemistry 58, 261-270
80. Rasmussen, J.G. et al. (2012) Activation of protease-activated receptor 2 induces VEGF independently of HIF-1. PLoS ONE 7, e46087
81. Yoshimura, K. et al. (2006) Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. Journal of Cellular Physiology 208, 64-76
82. McIntosh, K. et al. (2006) The immunogenicity of human adipose-derived cells: temporal changes in vitro . Stem Cells 24, 1246-1253
83. Dmitrieva, R.I. et al. (2012) Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 11, 377-383
84. Tarte, K. et al. (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115, 1549-1553
85. Lange, C. et al. (2007) Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. Journal of Cellular Physiology 213, 18-26
86. Schellenberg, A. et al. (2011) Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging 3, 873-888
87. Bourin, P. et al. (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International So. Cytotherapy 15, 641-648
88. Cramer, C. et al. (2010) Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells and Development 19, 1875-1884
89. Mischen, B.T. et al. (2008) Metabolic and functional characterization of human adipose-derived stem cells in tissue engineering. Plastic and Reconstructive Surgery 122, 725-738
90. Heiskanen, A. et al. (2007) N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197-202
91. Parker, a M. et al. (2007) Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy 9, 637-646
92. Al-Saqi, S.H. et al. (2014) Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells. Cytotherapy 16, 915-926
93. Atashi, F. et al. (2014) Autologous platelet-rich plasma: a biological supplement to enhance adipose-derived mesenchymal stem cell expansion. Tissue Engineering C, Methods
94. Bieback, K. et al. (2012) Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum. Cytotherapy 14, 570-583
95. Trojahn Kølle, S.-F. et al. (2013) Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use. Cytotherapy 15, 1086-1097
96. Abdallah, B.M. et al. (2006) Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39, 181-188
97. Yang, S. et al. (2012) Defined xenogeneic-free and hypoxic environment provides superior conditions for long-term expansion of human adipose-derived stem cells. Tissue Engineering C, Methods 18, 593-602
98. Fink, T. et al. (2011) Isolation and expansion of adipose-derived stem cells for tissue engineering. Frontiers in Bioscience (Elite Edition) 3, 256-263
99. Schirmaier, C. et al. (2014) Scale-up of adipose tissue-derived mesenchymal stem cell production in stirred single-use bioreactors under low-serum conditions. Engineering in Life Sciences 14, 292-303
100. Rojewski, M.T. et al. (2013) GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system. Cell Transplantation 22, 1981-2000
101. Martin, I., Smith, T. and Wendt, D. (2009) Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends in Biotechnology 27, 495-502
102. Valorani, M.G. et al. (2012) Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials. Cell Proliferation 45, 225-238
103. Weijers, E.M. et al. (2011) The influence of hypoxia and fibrinogen variants on the expansion and differentiation of adipose tissue-derived mesenchymal stem cells. Tissue Engineering A 17, 2675-2685
104. Fink, T. et al. (2004) Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia. Stem Cells 22, 1346-1355
105. Prasad, M. et al. (2014) Moderate hypoxia influences potassium outward currents in adipose-derived stem cells. PLoS ONE 9, e104912
106. Thangarajah, H. et al. (2009) IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells 27, 266-274
107. Rubina, K. et al. (2009) Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Engineering A 15, 2039-2050
108. Zachar, V. et al. (2011) Hypoxia and adipose-derived stem cell-based tissue regeneration and engineering. Expert Opinion on Biological Therapy 11, 775-786
109. Dominici, M. et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317
110. Committee for Advanced Therapies (CAT) European Medicines Agency (2011) Reflection paper on stem cell-based medicinal products EMA/CAT/571134/2009

Critical steps in the isolation and expansion of adipose-derived stem cells for translational therapy

  • S. Riis (a1), V. Zachar (a1), S. Boucher (a2), M.C. Vemuri (a2), C. P. Pennisi (a1) and T. Fink (a1)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed